Data News > Neutral Recommendation Issued On MRNA By Guggenheim

Neutral Recommendation Issued On MRNA By Guggenheim

By KlickAnalytics Data Insights  |   August 2, 2024 04:15PM ET

  • Guggenheim analyst issues NEUTRAL recommendation for MRNA on August 2, 2024 02:22PM ET.
  • The previous analyst recommendation was Neutral.
  • MRNA was trading at $85.46 at issue of the analyst recommendation.
  • The overall analyst consensus : BUY.
  • Current analyst recommendations are : 12 - Buy, 3 - Hold, 2 - Sell recommendations .

  • Historical Analyst Recommendations
    Latest 10 recommendations
    Report DateAnalyst CompanyActionPrevious GradeNew GradePrice when posted
    2024-08-02 Guggenheim Hold Neutral Neutral 85.46
    2024-08-02 Piper Sandler Hold Overweight Overweight 89.95
    2024-06-27 RBC Capital Hold Underperform Underperform 121.08
    2024-06-27 UBS Hold Buy Buy 121.08
    2024-06-27 Piper Sandler Hold Overweight Overweight 119.17
    2024-06-14 Cowen & Co. Hold Hold Hold 141.16
    2024-06-12 Oppenheimer Hold Outperform Outperform 148.39
    2024-06-10 Brookline Capital Hold Buy Buy 147.47
    2024-06-10 Morgan Stanley Hold Positive Positive 146.96
    2024-06-07 Jefferies Hold Buy Buy 152.03

    Historical Price Performance



    For more information:
  • Analyst Recommendations
  • Historical Price Targets
  • Earning Price Impact Analysis
  • Seasonality Analysis
  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.